The Potential Use of Artificial Intelligence in Irritable Bowel Syndrome Management

RA Vulpoi, M Luca, A Ciobanu, A Olteanu, O Bărboi… - Diagnostics, 2023 - mdpi.com
Irritable bowel syndrome (IBS) has a global prevalence of around 4.1% and is associated
with a low quality of life and increased healthcare costs. Current guidelines recommend that
IBS is diagnosed using the symptom-based Rome IV criteria. Despite this, when patients
seek medical attention, they are usually over-investigated. This issue might be resolved by
novel technologies in medicine, such as the use of Artificial Intelligence (AI). In this context,
this paper aims to review AI applications in IBS. AI in colonoscopy proved to be useful in …

[引用][C] The potential use of artificial intelligence in irritable bowel syndrome management. Diagnostics (Basel) 2023; 13 (21): 3336. doi: 10.3390 …

RA Vulpoi, M Luca, A Ciobanu - dx. doi. org/10.3390/diagnostics13213336
以上显示的是最相近的搜索结果。 查看全部搜索结果